Companies: โ€”ยทtotal market cap: โ€”
$ USD
companiesbycap
Menu
Global rankingSuperinvestors
Countries
๐Ÿ‡บ๐Ÿ‡ธUnited States๐Ÿ‡จ๐Ÿ‡ฆCanada๐Ÿ‡ฉ๐Ÿ‡ชGermany๐Ÿ‡ซ๐Ÿ‡ทFrance๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom๐Ÿ‡จ๐Ÿ‡ญSwitzerland๐Ÿ‡ฎ๐Ÿ‡ณIndia๐Ÿ‡ฏ๐Ÿ‡ตJapan
Categories
๐Ÿ’ปTechnology๐ŸฆFinancials๐Ÿ’ŠHealthcare๐Ÿ›๏ธConsumer Cyclical๐Ÿ“กCommunication๐ŸญIndustrials๐Ÿ›’Consumer DefensiveโšกEnergy
ALVO
Alvotech SA ALVO
$3.93
โ–ผ -1.18% 24H
3.116.349.5712.8016.032022-062023-062024-062025-062026-06

About

Alvotech S.A. is a global biopharmaceutical company specializing in the development, manufacturing, and delivery of high-quality biosimilar medicines. Biosimilars are biologic products highly similar to approved reference medicines, designed to expand patient access to affordable treatments for conditions in areas suchโ€ฆ

SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryLuxembourg
Employees1,012
TickerALVO

Statistics

Market Cap$1.23B
Revenue (TTM)$533.5M
Net Incomeโ€”
Net Marginโ€”
EPSโ€”
P/E42.40
P/S2.30
P/B-4.64
EV/EBITDA25.77
ROE-9.8%
Dividend Yieldโ€”
Price$3.93

Data: Twelve Data ยท Revenue = mcap / P/S

Alvotech SA (ALVO) โ€” Market Cap, Revenue, Net Income, P/E | companiesbycap